A randomized trial of naltrexone for smoking cessation

Addiction

Volumn 94, Issue 8, 1999, Pages 1227-1237

  Wong, Gilbert Y ^a   Wolter, Troy D ^b   Croghan, Gary A ^b   Croghan, Ivana T ^b   Offord, Kenneth P ^b   Hurt, Richard D ^b  

^a DEPARTMENT OF UROLOGY   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; NALTREXONE; NICOTINE; OPIATE ANTAGONIST;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EXPIRED AIR; FEMALE; HEADACHE; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SMOKING CESSATION; STOMACH PAIN; TRANSDERMAL DRUG ADMINISTRATION; VERTIGO; VOMITING; WITHDRAWAL SYNDROME;

EID: 0032820411     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.1999.948122713.x     Document Type: Article

References (16)

1. 1. VOLPICELLI, J. R., ALTERMAN, A. I., HAYASHIDA, M. & O'BRIEN, C. P. (1992) Naltrexone in the treatment of alcohol dependence, Archives of General Psychiatry, 49, 876-880.
2. 2. O'MALLEY, S. S., CROUP, R. S., WROBLEWSKI, J. W., LABRIOLA, D. F. & VOLPICELLI, J. R. (1995) Naltrexone in the treatment of alcohol dependence: a combined analysis of two trials, Psychiatric Annals, 25, 681-688.
3. 3. POMERLEAU, O. F., FERTIG, J. B., SEYLER, L. E. & JAFFE, J. (1983) Neuroendocrine reactivity to nicotine in smokers, Psychopharmacology, 82, 530-537.
4. 4. KARRAS, A. & KANE, J. M. (1980) Naloxone reduces cigarette smoking, Life Sciences, 27, 1541 1545.
5. 5. GORELICK, D. A., ROSE, J. & JARVIK, M. E. (1989) Effect of naloxone on cigarette smoking, Journal of Substance Abuse, 1, 153-159.
6. 6. NEMETH-COSLETT, R. & GRIFFITHS, R. R. (1986) Naloxone does not affect cigarette smoking, Psychopharmacology, 89, 261-264.
7. 7. SUTHERLAND, G., STAPLETON, J. A., RUSSELL, M. A. H. & FEYERABEND, C. (1995) Naltrexone, smoking behaviour and cigarette withdrawal, Psychopharmacology, 120, 418-425.
8. 8. HOUTSMULLER, E. J., CLEMMEY, P. A., SlGLER, L. A. & STITZER, M. L. (1997) Effects of naltrexone on smoking abstinence (abstract), Problems of drug dependence 1996; in: HARRIS, L. S. (Ed.) Proceedings of the 58th Annual Scientific Meeting, NIDA Research Monograph 174, p. 68 (Rockville, MD, National Institutes of Health).
9. 9. COVEY, L. S., GLASSMAN, A. G. & STETNER, F. (1996) Naltrexone for smoking cessation (abstract), Journal of Addictive Diseases, 15, 147.
10. 10. HURT, R. D., SACHS, D. P. L., GLOVER, E. D. et al. (1997) A comparison of sustained-release bupropion and placebo for smoking cessation, New England Journal of Medicine, 337, 1195-1202.
11. 11. HAMILTON, M. (1960) A rating scale for depression, Journal of Neurology, Neurosurgery & Psychiatry, 23, 56-62.
12. 12. TIFFANY, S. T. & DROBES, D. J. (1991) The development and initial validation of a questionnaire on smoking urges, British Journal of Addiction, 86, 1467-1476.
13. 13. PALMER, R. F. & BERENS, A. (1983) Double-blind study of the effect of naloxone on the pleasure of smoking, Federation Proceedings, 42, 654.
14. 14. HURT, R. D., LAUGER, G. G., OFFORD, K. P., KOTTKE, T. E. & DALE, L. C. (1990) Nicotine-replacement therapy with use of a transdermal nicotine patch - a randomized double-blind placebo-controlled trial, Mayo Clinic Proceedings, 65, 1529-1537.
15. 15. HURT, R. D., DALE, L, C., FREDRICKSON, P. A. et al. (1994) Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up, Journal of the American Medical Association, 271, 595-600.
16. 16. FIORE, M, C., SMITH, S. S., JORENBY, D. E. & BAKER, T. B. (1994) The effectiveness of the nicotine patch for smoking cessation. A meta-analysis, Journal of the American Medical Association, 271, 1940-1947.